It was too good of a message to pass up and too good to be buried in some "luv-thread" of Jack conversing with himself.
Don't give up Strongbuy; keep on saying it and saying it. And say it LOUD.
Hold that mirror up to their faces and let them have a good look at the things that they mostly choose to ignore.
You'll never get any thing other than the optimist from Jack. He seems to be some sort of company man; exactly which sort, I can't figure out. No matter.
Most of the rest are just hoping and dreaming that their dream will come true. They don't seem to care about life's little accidents. They won't listen to anything other the sugar-coated stuff.
Keep letttin' em have it though; they are due for some more bad news before too long here.
For Abbie Webb in the Virginias, Other than Level II, I don't know any market makers. And they SURELY don't cut me any checks. That would be a sweet gig to have though; stay home all day and have checks sent to me. Huh!
One last thing, for the majority of the hours of any day, it isn't MY VOICE telling you that this is too risky.
Therefore, it can ONLY BE YOUR VOICE warning you of the risk.
I would have to suppose that you are not listening to that little voice either? Que Sera........
*** You are talking to yourself and getting excited! What is there to get excited about $1.79? I was looking for a runaway overshoot at $20 pre-split with some positive news announcement. But, with the 10:1 RS, that's just a dream! The only reason I can think for this massive RS is for DVAX to shop themselves for a TO. Nobody wants to buy a $1.79 stock company ***
I'd give it, at BEST, 50-50 when it comes to him.
He panned 2 votes, a little over 2 years ago, and he voted negative both times. That speaks far more than any hootinany that you are reading lately.
How much has Dynavax done to actually change or improve whatever deficiencies there might be in heplisav (since 2012)?
Zero. Zilch. Nada. Nil.
What is it that they say about doing the same things over and over while expecting, yet, a different outcome?
I notice that none of the inmates here are willing to stick their necks out and offer you an explanation on the RS.
I particularly know that the "company man", mr. O. Jack (the founder and sprinkler of cheese for none other than Charles E. Cheese) knows the answer to your question and yet, declines an answer to you.
They now seem to want to act as if a 10 for 1 split never actually occurred here.
They only seem to want to believe that this junk stock went from $1 to $10 by it's own merits of NO PRODUCTS, NO REVENUES, and NO SOLID BUSINESS OPERATIONS.
Yeah, on that sort of thing, they really deserve to go to 50, 60, 70, 80, 90 dollars per share.
Maybe it would help more if they went out and got another loan or diluted off some more shares.......
Do any of you know what the perpetual stock rating for Dynavax has been from TSdotCom?
Sell, sell, sell. NOTHING but SELL.
Happy conferencing. Can't say that you haven't been warned (numerous times). You ARE playing with fire......
It was about the JP Morgan Conference next week.
I was wondering if Junkeevax was presenting and looking to see if the little "biotech goosestepper" had any thoughts on any of it.
Weeeeeeell, I read a little note in his "street" article and almost couldn't believe what I was seeing.
Just thought I'd share it with you all. Here is what it read:
SELL NOW: If you own any of the 900 stocks that TheStreet Quant Ratings has identified as a ‘Sell’…you could potentially lose EVERYTHING in the next 6-12 months
Of course, you wouldn't want to pay ANY ATTENTION to this part of the article:
Are any of these stocks screaming buys right now?
As clinical-stage biotechs, you should remember that these are high-risk types of investments that could crater if their lead experimental products flame out. That said, I'm most intrigued by Celladon's gene therapy approach, especially in light of Wall Street's apparent blessing. So personally, I'm thinking about buying shares ahead of its projected April data release for Mydicar
George Budwell owns shares of Dynavax Technologies. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
It's in an article from Motel-ee Ghouls, written by some long named George Budwell.
Georgie? You here?
It also mentions NVAX and one or two other stocks. It contains the standard "Hope for the best" and "To the moon" type numbers and sentiment.
But Georgie, why did you decide to skip the 1 for 10 reverse split? Where is the truth in advertising there?
Anyways, it's your big 15 minutes, so go and enjoy it.......
Did you catch that last sentence? I believe that we have heard someone else say that, right here on this MB. And up to this very point in time, he has been right in his views.
" He said it was possible that the whole vaccine research industry could move to other
countries and the United States should ask if this was acceptable. "
A good indication the dynavax and helpless_on_a_slab haven't seen the last of good ole' Dr. Doom.....
It's sad, but it's not altogether surprising to see that you are cheerleading Grey and his merry band using an 8K as an official earnings report. It's actually kind of scandalous, but I guess it doesn't bother you.
And $122MM is NOT going to fix this company's problems on the road to attempted commercialization.
They have wasted far more and come away with just as much of nothing. You know where that future money will come from; dilution, dilution, dilution.
Actual "sales" may not be a future reality. This is definite risk of non-approval to this company's "candidate", and when that happens it will be, "Boom, Kapow and down went the stock".
Recommendation: Save your money and don't risk the losses. There are plenty of better stocks out there than this sad little one.
Check it out!
I told you no one was going to buy this company Ctic. Even your "hero" isn't interested in them.
Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015
BY Adam Feuerstein
.....and guess what? DVAX doesn't count anywhere among them!
Yes, the little, bald, biotech #$%$ is out with a list of predictions and Dynavax doesn't appear on that list anywhere at all. I told you, no one going to buy this flaming disaster, no one even seems to be interested in them. That is why they couldn't get a loan for $40MM at a regular bank. They had to go to some pay-day-loan, wall street equivalent. If PukeeStein doesn't have any love for DVAX this year, that should tell you something. He most likely won't next year, either. Ever notice that TSdotCom NEVER changes their sentiment about DVAX from perpetual SELL? I guess that doesn't say anything either. Happy reading......
Go look for his article. It's listed under this:
Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015
BY Adam Feuerstein
Amen Brother, you got my vote!
But you're wasting your time trying to tell these ostriches. All these dopes want to hear is $30,$40, $80 by July on some superfluous fluffery.
No products, no revenues; a 1:10 split and a whopper $40MM loan which will need to be paid back soon enough. But all these drips want to think about is DSMB recommendations for vaccine "CANDIDATE" with a spotty, checkered past.
Before long it will be time for "losses reporting"; and they will expect that the company will stay at $1.75 and $1.80 as if by magic. It's just what ostriches do, I suppose......
No, no, none of that is really a stretch at all. You're right on target there. :-P
Neither Merck nor BMS have ANYTHING presently to do with Dynavax, Heplisav, SD101 or L,M,N,O, or P or any other corporate sponsored acronym.
Please. YOU are SO stretching some silliness in a pathetic attempt to try to make DVAX look better than what it presently actually is.
Keep dreaming friend......
Ah, yeah......well,...... NO.
Here is the real truth to your bunk:
This is from Matthew Herper of Forbes (and it had NOTHING to do with Heplisav)
I cover science and medicine, and believe this is biology's century.
Pharma & Healthcare 12/30/2014 @ 7:00AM 34,078 views
The Most Important New Drug Of 2014
It’s a tie.
Since 2012, I’ve been picking the most important new medicine approved each year. It’s always a tight competition, but this year the two obvious winners are so alike that I think it’s not fair to give either an edge. They are: Keytruda from Merck and Opdivo from Bristol-Myers Squibb
Dynavax is KNOWN for developing PRODUCTS????? WHAT PRODUCTS???
Dynavax is mostly known for running endless trials.
And ===== they have NO PRODUCTS (period), to date.
I'm sure that you all believe that DVAX is going to $40 per share without any approved product and a brand new $40MM shiny new loan to pay back. But, you see, there is this thing called "reality" folks.
This guy xu has been rating DVAX since 2010 and he has a 67% accuracy rate? With DVAX?
Please! LOAD of bull.......